Neogenomics (NEO) Amortizatization of Intangibles (2012 - 2026)
Neogenomics (NEO) reported Amortizatization of Intangibles of $7.6 million for Q1 2026, down 8.72% on a YoY basis from $8.4 million in Q1 2025, and up 134.37% quarter-over-quarter from -$22.2 million in Q4 2025.
Neogenomics (NEO) Amortizatization of Intangibles (2012 - 2026) Analysis & Trends
Neogenomics has reported Amortizatization of Intangibles for 15 years, with the latest figure at $7.6 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 8.72% year-over-year to $7.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 95.42% YoY), and the FY2025 full-year result was $1.9 million, down 29.91% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $7.6 million, up from -$22.2 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $8.8 million in Q3 2023, with the low at -$22.8 million in Q4 2022.
- Historically, Amortizatization of Intangibles has averaged $2.4 million across 5 years, with a median of $7.6 million in 2025.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles slumped 3561.76% — and 2025, when it jumped 1133.33%.
- Neogenomics' Amortizatization of Intangibles stood at -$22.8 million in 2022, then jumped by 102.96% to $676000.0 in 2023, then climbed by 1.18% to $684000.0 in 2024, then plunged by 3347.08% to -$22.2 million in 2025, then jumped by 134.37% to $7.6 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $7.6 million (Q1 2026), -$22.2 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 171.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 430.00 Mn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 434.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | - |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 7.10 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 18.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | - |
| 10 | Neogenomics | 1.46 Bn | 1.32 Bn | 80.86 Mn | 7.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.63 Mn |
| Mar 31, 2026 | 7.63 Mn |
| Dec 31, 2025 | -22.21 Mn |
| Dec 31, 2025 | -22.21 Mn |
| Sep 30, 2025 | 7.63 Mn |
| Sep 30, 2025 | 7.63 Mn |
| Jun 30, 2025 | 8.12 Mn |
| Jun 30, 2025 | 8.12 Mn |
| Mar 31, 2025 | 8.36 Mn |
| Mar 31, 2025 | 8.36 Mn |
| Dec 31, 2024 | 684,000.00 |
| Dec 31, 2024 | 684,000.00 |
| Sep 30, 2024 | 8.36 Mn |
| Sep 30, 2024 | 8.36 Mn |
| Jun 30, 2024 | 8.36 Mn |
| Jun 30, 2024 | 8.36 Mn |
| Mar 31, 2024 | 678,000.00 |
| Mar 31, 2024 | 678,000.00 |
| Dec 31, 2023 | 676,000.00 |
| Dec 31, 2023 | 676,000.00 |